Orthopedic Implants Market Size Worth USD 64.72 Billion in 2032 | Emergen Research

Increasing prevalence of orthopedic disorders, technological advancements in the field of orthopedic implants, and rising demand for orthopedic implants are key factors driving Orthopedic Implants Market revenue growth.

Vancouver, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global orthopedic implants market size was USD 35.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.3% during the forecast period. The surge is attributed to the increasing prevalence of orthopedic disorders, advancements in orthopedic implant technology, and a growing demand for these implants globally.

Orthopedic implants, crucial in supporting or replacing damaged bones, are predominantly made from materials like stainless steel, titanium, cobalt-based alloys, and polymers. According to the World Health Organization (WHO), over 1.71 billion people globally suffer from musculoskeletal diseases, emphasizing the critical role orthopedic implants play in addressing these conditions.

Key Drivers of Market Growth

One pivotal factor driving the market is the adoption of Three Dimensional (3D) printing technology, revolutionizing orthopedic implant manufacturing. 3D printing allows the creation of patient-specific implants, enhancing precision in orthopedic procedures. This technology empowers surgeons to plan complex surgeries meticulously, resulting in optimal implant sizing and placement, ultimately improving patient outcomes.

However, the high cost of orthopedic implants poses a challenge to market growth. Factors contributing to this include limited knowledge of implant costs among surgeons, confidentiality agreements, industry competition, and the introduction of newer, more expensive technologies. Improving transparency, educating surgeons about costs, and promoting evidence-based decision-making are crucial to address this issue.

Innovations and Trends

A notable trend in the market is the development of multifunctional smart bone implants. These bioelectronic devices aim to provide personalized and continuous therapeutic interventions, optimizing the performance of bone implants and reducing surgical revision rates. Challenges persist, but these implants represent a promising avenue for improving long-term implant survival and patient outcomes.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2479

Product Insights

The orthobiologics segment is expected to dominate the market during the forecast period. These organic and synthetic materials enhance tissue healing, aligning with the trend toward precision medicine and patient-centered care. Orthobiologics offer alternatives to traditional bone grafting, reducing donor site morbidity and showing promise in various orthopedic procedures.

The reconstructive joint replacement segment is poised for moderately fast revenue growth, driven by the increasing prevalence of joint issues, especially in the aging population. Rising awareness among patients and healthcare providers is also contributing to the segment’s growth.

Biomaterial Insights

The metallic biomaterials segment is expected to hold a significantly large revenue share, thanks to their proven safety, excellent mechanical properties, corrosion resistance, and biocompatibility. The ceramic biomaterials segment is anticipated to register the fastest revenue growth, driven by wear resilience and biochemical inertness.

Regional Insights

North America led the market in 2022, driven by the rising number of patients requiring hip or knee replacements. The region is witnessing an increase in orthopedic procedures, and the prevalence of polypharmacy is contributing to market growth.

The Asia Pacific market is expected to register the fastest revenue growth, fueled by an increasing number of spinal cord injuries and technological advancements in orthopedic implants. China, a major player in the market, is utilizing 3D printing technology to produce customized implants tailored to the Chinese market.

Europe is anticipated to account for a considerably large revenue share, owing to the adoption of newer implant designs and materials focused on improving patient outcomes. The region’s commitment to Research & Development and stringent quality and safety standards drive innovations in orthopedic implants.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2479

Scope of Research

Report Details Outcome
Market Size in 2022 USD 35.30 Billion
CAGR (2023–2032) 6.3%
Revenue Forecast To 2032 USD 64.72 Billion
Base Year For Estimation 2022
Historical Data 2019-2021
Forecast Period 2023–2032
Quantitative Units Revenue in USD Billion and CAGR in % from 2023 to 2032
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered Product, biomaterial, type, end-use, and region
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country Scope U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies Profiled Stryker, DePuy Synthes, Zimmer Biomet, Smith & Nephew, Orthopedic Implant Company, DJO Global, Arthrex, Inc., NuVasive, Inc., Evonic, Globus Medical, Health Canada, Kyocera Medical Technologies, Inc., Teijin Nakashima Medical Co., Ltd, HMC Orthcare Pvt. Ltd., Stryker Corporation, Smith & Nephew plc, Medtronic plc, Johnson & Johnson, CONMED Corporation, and Colfax Corporation (DJO GLOBAL LLC)
Customization Scope 10 hours of free customization and expert consultation

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2479

Major Companies and Competitive Landscape

The global orthopedic implants market is moderately fragmented, with many large and medium-sized players accounting for majority of market revenue. Major businesses are using a variety of tactics, making mergers and acquisitions, strategic agreements, and contracts, as well as creating, experimenting with, and introducing more efficient orthopedic implants solutions. Some major players included in the global orthopedic implants market report are:

  • Stryker
  • DePuy Synthes
  • Zimmer Biomet
  • Smith & Nephew
  • Orthopedic Implant Company
  • DJO Global
  • Arthrex, Inc.
  • NuVasive, Inc.
  • Evonic
  • Globus Medical
  • Health Canada
  • Kyocera Medical Technologies, Inc.
  • Teijin Nakashima Medical Co., Ltd.
  • HMC Orthcare Pvt. Ltd.
  • Stryker Corporation
  • Smith & Nephew plc
  • Medtronic plc
  • Johnson & Johnson
  • CONMED Corporation
  • Colfax Corporation (DJO GLOBAL LLC)

Strategic Development

  • On 11 November 2022, General Electric (GE) Additive and Orchid Orthopedic Solutions collaborated to advance Additive Manufacturing (AM) in the orthopedic implant sector. Orchid invested in GE Additive’s Electron Beam Melting (EBM) technology, with the first machines installed in 2022. Orchid plans to use the technology to manufacture large orthopedic implants, including knee components and acetabular cups. EBM enables the mass production of parts by stacking them closely without compromising quality, resulting in consistent material properties for thin and bulky geometries. The collaboration aims to raise awareness of EBM technology for 3D metal-printed orthopedic implants.
  • On 11 October 2022, Orthofix and SeaSpine merged in an all-stock deal to form a prominent global spine and orthopedics company. With products available in 68 countries and revenues of approximately USD 693 million, this merger combines complementary portfolios of biologics, orthopedic solutions, and surgical navigation systems. The company will offer a wide range of biologics and regenerative technologies, serving both the spine and orthopedics fields. In addition, the companies expect substantial cost savings, meaningful cross-selling opportunities, and an enhanced ability to reach larger distribution partners.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/orthopedic-implants-market

For the purpose of this report, Emergen Research has segmented the global orthopedic implants market on the basis of type, application, deployment, enterprise size, component, vertical and region:

  • Product Outlook (Revenue, USD Billion; 2019-2032)
    • Reconstructive Joint Replacements
    • Spinal Implants
    • Dental Implants
    • Trauma
    • Orthobiologics
    • Others
  • Biomaterial Outlook (Revenue, USD Billion; 2019-2032)
    • Metallic Biomaterials
    • Ceramic Biomaterials
    • Polymeric Biomaterials
  • Type Outlook (Revenue, USD Billion; 2019-2032)
    • Knee
    • Hip
    • Wrist and Shoulder
    • Dental
    • Spine
    • Ankle
  • End-use Outlook (Revenue, USD Billion; 2019-2032)
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa
    • Hospitals
    • Homecare
    • Outpatient Facilities
    • Research and Manufacturing

Curated Reports You Shouldn’t Miss: Dive In Now!

Human Papilloma Virus Testing and Pap Test Market, By Test Type (HPV Testing and Pap Smear Test), By Technology [Polymerase Chain Reaction (PCR) and Others], By Application, By End-Use, and By Region Forecast to 2032

Endoluminal Suturing Devices Market, By Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, and Others), By End-Use, and By Region Forecast to 2030

Renal Denervation Market, By Technology (Radiofrequency, Ultrasound, Micro-infusion, and Others), By End-Use (Hospital, Specialty Clinics, and Others), and By Region Forecast to 2032

Surgical Retractors Market By Product (Handheld, Self-Retaining, Table-Mounted, Wire Surgical, and Accessories), By Design, By Usage, By Application, By End-Use, and By Region Forecast to 2030

Sinus Dilation Devices Market By Product (Balloon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, and Others), By Procedure (Standalone, Hybrid, and Others), By End-use, and By Region Forecast To 2030

Disposable Medical Device Sensors Market, By Product (Biosensors, Pressure Sensors, Accelerometers, and Others), By Type (Strip Sensors, Wearable Sensors, and Others), By Application, and By Region Forecast to 2030

Medical Electrodes Market, By Product Type (Surface Electrodes and Needle Electrodes), By Usability (Disposable and Reusable), By Modality, By Application (Cardiology, Neurophysiology, and Others), and By Region Forecast to 2030

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.